OR WAIT null SECS
February 23, 2022
Semarion raises £2.14 million GBP (US$2.89 million) seed funding to support the commercial development of Semarion’s SemaCyte cell assaying platform.
February 22, 2022
Noema Pharma announces first patient dosed in its Phase IIb clinical trial of mGluR5 inhibitor NOE-101 in trigeminal neuralgia.
Hoffman Neopac has signed a partnership with Saperatec to begin recycling aluminum laminate composites upon its opening in mid-2023.
The European Medicines Regulatory Network has adopted a Common Standard for the electronic product information on medicines in the European Union.
Quotient Sciences announces that it has integrated drug substance into its flagship Translational Pharmaceutics platform.
February 21, 2022
The turnkey facilities will promote scalable vaccine production for an end-to-end manufacturing network for mRNA-based vaccines in Africa.
February 18, 2022
The company has announced plans to establish a commercial presence in six European countries.
EC has approved Oxbryta (voxelotor) as a treatment for hemolytic anemia in patients with Sickle Cell Disease (SCD) age 12 years and older.
The EC approved AstraZeneca’s Saphenlo (anifrolumab) for the treatment of active autoantibody-positive systemic lupus erythematosus.
February 16, 2022
Guidance published during the pandemic has been updated to include content requirements for summary safety reports.